Total Serum Transforming Growth Factor‐β1 Is Elevated in the Entire Spectrum of Genetic Aortic Syndromes
暂无分享,去创建一个
P. Robinson | S. Blankenberg | T. Zeller | K. Kutsche | B. Keyser | J. Berger | T. Mir | T. Kölbel | Y. von Kodolitsch | M. Rybczynski | B. Goldmann | S. Sheikhzadeh | M. Hillebrand | N. Millot | S. Gerth
[1] S. Blankenberg,et al. Dural ectasia in Loeys–Dietz syndrome: comprehensive study of 30 patients with a TGFBR1 or TGFBR2 mutation , 2014, Clinical genetics.
[2] S. Blankenberg,et al. Comprehensive analysis of dural ectasia in 150 patients with a causative FBN1 mutation , 2014, Clinical genetics.
[3] G. Rosenberger,et al. A 1-bp duplication in TGFB2 in three family members with a syndromic form of thoracic aortic aneurysm , 2013, European Journal of Human Genetics.
[4] H. Dietz,et al. Loeys–Dietz syndrome: a primer for diagnosis and management , 2014, Genetics in Medicine.
[5] R. Pyeritz. Heritable thoracic aortic disorders , 2014, Current opinion in cardiology.
[6] A. Zwinderman,et al. Circulating transforming growth factor-β as a prognostic biomarker in Marfan syndrome. , 2013, International journal of cardiology.
[7] B. Loeys,et al. Genetics of thoracic aortic aneurysm: at the crossroad of transforming growth factor-β signaling and vascular smooth muscle cell contractility. , 2013, Circulation research.
[8] J. Elefteriades,et al. Biomarkers in TAA-the Holy Grail. , 2013, Progress in cardiovascular diseases.
[9] Paul Coucke,et al. Novel MYH11 and ACTA2 mutations reveal a role for enhanced TGFβ signaling in FTAAD. , 2013, International journal of cardiology.
[10] S. Takamoto,et al. Circulating transforming growth factor β-1 level in Japanese patients with Marfan syndrome. , 2013, International heart journal.
[11] Y. Suh,et al. Positive correlation between the dysregulation of transforming growth factor-β1 and aneurysmal pathological changes in patients with Marfan syndrome. , 2013, Circulation journal : official journal of the Japanese Circulation Society.
[12] J. Coselli,et al. Notch Signaling in Descending Thoracic Aortic Aneurysm and Dissection , 2012, PloS one.
[13] E. Boerwinkle,et al. Normal limits in relation to age, body size and gender of two-dimensional echocardiographic aortic root dimensions in persons ≥15 years of age. , 2012, The American journal of cardiology.
[14] H. Dietz,et al. Matrix‐dependent perturbation of TGFβ signaling and disease , 2012, FEBS letters.
[15] R. Pyeritz. Evaluation of the adolescent or adult with some features of Marfan syndrome , 2012, Genetics in Medicine.
[16] D. Sillence,et al. Mutations in the TGFβ binding-protein-like domain 5 of FBN1 are responsible for acromicric and geleophysic dysplasias. , 2011, American journal of human genetics.
[17] Laurence Faivre,et al. The revised Ghent nosology for the Marfan syndrome , 2010, Journal of Medical Genetics.
[18] Stephan Willems,et al. Augmentation index relates to progression of aortic disease in adults with Marfan syndrome. , 2009, American journal of hypertension.
[19] H. Dietz,et al. Circulating Transforming Growth Factor-&bgr; in Marfan Syndrome , 2009, Circulation.
[20] A. Al Haj Zen,et al. Syndromic and non‐syndromic aneurysms of the human ascending aorta share activation of the Smad2 pathway , 2009, The Journal of pathology.
[21] P. Robinson,et al. The spectrum of syndromes and manifestations in individuals screened for suspected Marfan syndrome , 2008, American journal of medical genetics. Part A.
[22] A. Dart,et al. Angiotensin II blockade in Marfan's syndrome. , 2008, The New England journal of medicine.
[23] J. Rosenbloom,et al. Angiotensin II blockade in Marfan's syndrome. , 2008, The New England journal of medicine.
[24] A. Dart,et al. Effect of perindopril on large artery stiffness and aortic root diameter in patients with Marfan syndrome: a randomized controlled trial. , 2007, JAMA.
[25] M Claustres,et al. Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study. , 2007, American journal of human genetics.
[26] P. Byers,et al. Aneurysm syndromes caused by mutations in the TGF-beta receptor. , 2006, The New England journal of medicine.
[27] George H. Thomas,et al. Aneurysm Syndromes Caused by Mutations in the TGF-β Receptor , 2006 .
[28] Marc K. Halushka,et al. Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome , 2006, Science.
[29] William Stewart,et al. Recommendations for chamber quantification. , 2006, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.
[30] Wolfram Kress,et al. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2 , 2005, Nature Genetics.
[31] R E Pyeritz,et al. Revised diagnostic criteria for the Marfan syndrome. , 1996, American journal of medical genetics.
[32] E. F. Du Bois,et al. A formula to estimate the approximate surface area if height and weight be known. 1916. , 1989, Nutrition.
[33] D. DuBois,et al. A formula to estimate the approximate surface area if height and weight be known , 1989 .